Status:
COMPLETED
Feasibility Study of a Software Application for Patients Hospitalized After Suicidal Ideation or Suicide Attempts
Lead Sponsor:
Oui Therapeutics, Inc.
Conditions:
Suicide, Attempted
Suicidal Ideation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The primary objective of this feasibility study is to assess the feasibility, and usability of a software application to deliver targeted interactive exercises to patients recently hospitalized for su...
Eligibility Criteria
Inclusion
- English speaking male or female patients, 18-70 years
- Patients who have attempted suicide and voluntarily admitted themselves to an inpatient psychiatric unit or have clinically significant suicidal ideation and intent to harm themselves and are still on the inpatient psychiatric unit.
- Understand written and spoken English
- Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
- Willing and able to complete enrollment procedures
- Able to understand the nature of the study and provide written informed consent
- Able and willing to provide at least two verifiable contacts for emergency or tracking purposes.
Exclusion
- Patients with active psychosis
- Patients who are acutely intoxicated at the time of enrollment
- Currently enrolled in other treatment studies for the symptoms and behaviors targeted
- Patients who are cognitively impaired
- Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit (e.g. critically ill patients) profile with respect to the software application that delivers interactive exercises.
Key Trial Info
Start Date :
May 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04295382
Start Date
May 12 2020
End Date
July 1 2021
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale-New Haven Hospital
New Haven, Connecticut, United States, 06519